TY - JOUR
T1 - Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
AU - Hiraoka, N.
AU - Ino, Y.
AU - Yamazaki-Itoh, R.
AU - Kanai, Y.
AU - Kosuge, T.
AU - Shimada, K.
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (NH), Princess Takamatsu Foundation (10-24216) (NH), Takeda Science Foundation (NH), and Cancer Research and Development Fund (NH). The authors have no conflicting financial, professional, or personal interests. We thank Ms Keiko Gomisawa for excellent technical helps and Drs Hidenori Ojima, Minoru Esaki, Satoshi Nara, and Yoji Kishi for useful discussion.
Publisher Copyright:
© 2015 Cancer Research UK.
PY - 2015/5/26
Y1 - 2015/5/26
N2 - Background:Host immunity has critical roles in tumour surveillance. Tertiary lymphoid organs (TLOs) are induced in various inflamed tissues. The aim of this study was to investigate the clinicopathological and pathobiological characteristics of tumour microenvironment in pancreatic ductal carcinoma (PDC) with TLOs.Methods:We examined 534 PDCs to investigate the clinicopathological impact of TLOs and their association with tumour-infiltrating immune cells, the cytokine milieu, and tissue characteristics.Results:There were two different localisations of PDC-associated TLOs, intratumoral and peritumoral. A better outcome was observed in patients with intratumoral TLOs, and this was independent of other survival factors. The PDC tissues with intratumoral TLOs showed significantly higher infiltration of T and B cells and lower infiltration of immunosuppressive cells, as well as significantly higher expression of Th1- and Th17-related genes. Tertiary lymphoid organs developed with an association with arterioles, venules, and nerves. These structures were reduced in an association with cancer invasion in PDC tissues, except for those with intratumoral TLOs. The PDC tissues with intratumoral TLOs had capillaries consisting of mature endothelial cells covered by pericytes.Conclusions:Our results suggest that the presence of intratumoral TLOs represents a microenvironment that has an active immune reaction, and shows a relatively intact vascular network retained.
AB - Background:Host immunity has critical roles in tumour surveillance. Tertiary lymphoid organs (TLOs) are induced in various inflamed tissues. The aim of this study was to investigate the clinicopathological and pathobiological characteristics of tumour microenvironment in pancreatic ductal carcinoma (PDC) with TLOs.Methods:We examined 534 PDCs to investigate the clinicopathological impact of TLOs and their association with tumour-infiltrating immune cells, the cytokine milieu, and tissue characteristics.Results:There were two different localisations of PDC-associated TLOs, intratumoral and peritumoral. A better outcome was observed in patients with intratumoral TLOs, and this was independent of other survival factors. The PDC tissues with intratumoral TLOs showed significantly higher infiltration of T and B cells and lower infiltration of immunosuppressive cells, as well as significantly higher expression of Th1- and Th17-related genes. Tertiary lymphoid organs developed with an association with arterioles, venules, and nerves. These structures were reduced in an association with cancer invasion in PDC tissues, except for those with intratumoral TLOs. The PDC tissues with intratumoral TLOs had capillaries consisting of mature endothelial cells covered by pericytes.Conclusions:Our results suggest that the presence of intratumoral TLOs represents a microenvironment that has an active immune reaction, and shows a relatively intact vascular network retained.
KW - pancreatic cancer
KW - tertiary lymphoid organ
KW - tumour immunity
KW - vessel
UR - http://www.scopus.com/inward/record.url?scp=84930042269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930042269&partnerID=8YFLogxK
U2 - 10.1038/bjc.2015.145
DO - 10.1038/bjc.2015.145
M3 - Article
C2 - 25942397
AN - SCOPUS:84930042269
SN - 0007-0920
VL - 112
SP - 1782
EP - 1790
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 11
ER -